ACADIA Pharmaceuticals Inc (ACAD)
14.79
-0.06
(-0.40%)
USD |
NASDAQ |
May 17, 16:00
14.78
-0.02
(-0.10%)
After-Hours: 20:00
ACADIA Pharmaceuticals Price to Book Value: 5.266 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 5.266 |
| May 16, 2024 | 5.287 |
| May 15, 2024 | 5.383 |
| May 14, 2024 | 5.291 |
| May 13, 2024 | 5.405 |
| May 10, 2024 | 5.430 |
| May 09, 2024 | 5.416 |
| May 08, 2024 | 6.099 |
| May 07, 2024 | 6.142 |
| May 06, 2024 | 6.053 |
| May 03, 2024 | 6.071 |
| May 02, 2024 | 6.081 |
| May 01, 2024 | 6.071 |
| April 30, 2024 | 5.950 |
| April 29, 2024 | 6.088 |
| April 26, 2024 | 5.949 |
| April 25, 2024 | 5.806 |
| April 24, 2024 | 5.906 |
| April 23, 2024 | 5.960 |
| April 22, 2024 | 6.049 |
| April 19, 2024 | 5.979 |
| April 18, 2024 | 6.068 |
| April 17, 2024 | 6.111 |
| April 16, 2024 | 6.072 |
| April 15, 2024 | 6.004 |
| Date | Value |
|---|---|
| April 12, 2024 | 6.093 |
| April 11, 2024 | 6.189 |
| April 10, 2024 | 6.303 |
| April 09, 2024 | 6.452 |
| April 08, 2024 | 6.328 |
| April 05, 2024 | 6.402 |
| April 04, 2024 | 6.416 |
| April 03, 2024 | 6.548 |
| April 02, 2024 | 6.438 |
| April 01, 2024 | 6.491 |
| March 31, 2024 | |
| March 28, 2024 | 7.056 |
| March 27, 2024 | 6.946 |
| March 26, 2024 | 6.789 |
| March 25, 2024 | 6.808 |
| March 22, 2024 | 6.850 |
| March 21, 2024 | 7.026 |
| March 20, 2024 | 7.121 |
| March 19, 2024 | 7.136 |
| March 18, 2024 | 7.144 |
| March 15, 2024 | 7.053 |
| March 14, 2024 | 7.148 |
| March 13, 2024 | 7.465 |
| March 12, 2024 | 7.625 |
| March 11, 2024 | 9.209 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.488
Minimum
Sep 14 2021
16.35
Maximum
Sep 16 2019
8.743
Average
8.864
Median
Apr 13 2022
Price to Book Value Benchmarks
| Regulus Therapeutics Inc | 1.217 |
| Amylyx Pharmaceuticals Inc | 0.3836 |
| Alnylam Pharmaceuticals Inc | -- |
| Cassava Sciences Inc | 14.11 |
| Oragenics Inc | 6.627 |
Price to Book Value Related Metrics
| PS Ratio | 3.002 |
| Price to Free Cash Flow | 38.34 |
| Price | 14.79 |
| Earnings Yield | -0.07% |
| Market Cap | 2.444B |